Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandonment, Abbott, accessibility, acquaintance, arthroplasty, Australian, automated, Boaz, breakdown, Capricor, civilian, closest, complimentary, conclusion, contemplated, COO, deal, Deloitte, device, digit, Division, downturn, driven, earlier, ECI, embryonic, ERS, fact, fit, fluctuate, focused, focusing, Forum, Gaza, GM, Hezbollah, hypersensitivity, instrument, IR, Islamist, isometric, KFDA, Korean, KOSDAQ, KRW, lapse, Lebanese, leg, magnitude, Master, militia, missile, mother, motor, moving, needle, notional, NV, outsource, partnership, pathogen, payroll, perspective, pharma, physician, preeclampsia, Privileged, qualification, repair, revert, Rock, scaffold, settle, Shiite, sovereign, Strip, summer, surgical, synthetic, syringe, Telecom, tendon, tenure, Tigenix, true, undergoing, unilaterally, upcoming, vial, VP, winding, women, Won
Removed:
Aldagen, artery, birth, clean, collectively, commencing, consumer, enable, exhibit, expanding, extend, identifiable, inspector, issuable, launch, leasing, Legislation, notice, Omer, OTC, outlined, overallotment, PAD, periodically, placement, prepare, random, real, rental, resale, reserved, standardized, supplement, surgery, termed, vacation, widen
Filing tables
Filing exhibits
- 10-K Annual report
- 10.16 Exhibit 10.16
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- Download Excel data file
- View Excel data file
PLUR similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the "Company") for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350 that, to my knowledge:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Dated: September 11, 2014
/s/ Boaz Gur-Lavie Boaz Gur-Lavie Chief Financial Officer |